Avanir Settles With Sandoz Over Nuedexta Generic Plans
Avanir Pharmaceuticals Inc. has settled a suit in Delaware federal court accusing Sandoz Inc.'s planned generic version of involuntary-emotion treatment Nuedexta of infringing three patents, the company announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article